Trilogy is a privately-owned company, established in Frankfurt am Main, Germany by its 3 founding partners in 2002. Trilogy Writing & Consulting GmbH is now owned by its 4 Senior Partners: Barry Drees, Douglas Fiebig, Lisa Chamberlain James, and Julia Forjanic Klapproth. All of the owning partners of the company are involved in the company’s day-to-day operational business. They are medical writers and managers.
Trilogy Writing & Consulting Ltd was established as Trilogy’s UK subsidiary operation in 2011, and Trilogy Writing & Consulting Inc was established as Trilogy’s US subsidiary operation in 2016. These are 100% subsidiaries of the German company.
Trilogy specialises in medical writing and our business does nothing else.
Trilogy’s business model is to offer high-end medical writing that goes beyond just making sure a document is structured properly: it involves content-driven sanity checks, a sense of ownership of the documents, and offering strategic support on all areas of document production (from advising on best options for data presentation and helping teams focus on messages, to suggestions on best practice for review scenarios, coordinating team timelines, and proactively managing cross-functional input). We have a hand-picked team of medical writers and QC experts, many of whom have been trained within our organisation.
All our writers are scientists and career medical writers. Many of our senior writers have postgraduate qualifications in Life Sciences. We have a team of more than 60 medical writing staff.